The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced nonsmall cell lung cancer receiving palliative chemotherapy
β Scribed by Mark Vincent; George Dranitsaris; Sunil Verma; Cathy Lau; Pere Gascon; Simon Van Belle; Heinz Ludwig
- Publisher
- Springer-Verlag
- Year
- 2006
- Tongue
- English
- Weight
- 183 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0941-4355
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND: Patientβreported outcomes have shown independent prognostic value for patients with nonsmall cell lung cancer (NSCLC). However, translating patientβreported outcomes into useful prognostic information for individual patients has been problematic. ## METHODS: A total of
## Abstract ## BACKGROUND: Involuntary weight loss is a major contributor to mortality and morbidity in patients with advanced cancer. Nutritional intervention with fish oil (FO)βderived eicosapentaenoic acid (EPA) may prevent deterioration of body composition. This study compared intervention wit
A recent article by Hotta and colleagues 1 reports that survival of patients with nonsmall cell lung cancer (NSCLC) improved slowly over time from 1982 to 2002. Authors pooled together 121 phase 3 trials (42,768 patients overall),